Header Logo

Connection

Katie Nason to Risk Factors

This is a "connection" page, showing publications Katie Nason has written about Risk Factors.
Connection Strength

0.619
  1. Attaar A, Tam V, Nason KS. Risk Factors for Prolonged Air Leak After Pulmonary Resection: A Systematic Review and Meta-analysis. Ann Surg. 2020 05; 271(5):834-844.
    View in: PubMed
    Score: 0.081
  2. Tam V, Luketich JD, Levy RM, Christie NA, Awais O, Shende M, Nason KS. Mesh cruroplasty in laparoscopic repair of paraesophageal hernias?is?not associated with better long-term outcomes compared?to?primary repair. Am J Surg. 2017 Oct; 214(4):651-656.
    View in: PubMed
    Score: 0.066
  3. Nason KS. Acute Intraoperative Pulmonary Aspiration. Thorac Surg Clin. 2015 Aug; 25(3):301-7.
    View in: PubMed
    Score: 0.058
  4. Weksler B, Pennathur A, Sullivan JL, Nason KS. Resection of thymoma should include nodal sampling. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):737-42.
    View in: PubMed
    Score: 0.055
  5. Zahoor H, Luketich JD, Levy RM, Awais O, Winger DG, Gibson MK, Nason KS. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma. J Thorac Cardiovasc Surg. 2015 Feb; 149(2):538-47.
    View in: PubMed
    Score: 0.055
  6. Nason KS, Murphy T, Schindler J, Schipper PH, Hoppo T, Diggs BS, Sauer DA, Shaheen NJ, Morris CD, Jobe BA. A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol. 2013 Oct; 47(9):762-8.
    View in: PubMed
    Score: 0.051
  7. Shah RD, Luketich JD, Schuchert MJ, Christie NA, Pennathur A, Landreneau RJ, Nason KS. Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg. 2012 Mar; 93(3):897-903; discussion 903-4.
    View in: PubMed
    Score: 0.045
  8. Nason KS, Wichienkuer PP, Awais O, Schuchert MJ, Luketich JD, O'Rourke RW, Hunter JG, Morris CD, Jobe BA. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg. 2011 Jul; 146(7):851-8.
    View in: PubMed
    Score: 0.044
  9. Nason KS, Luketich JD, Qureshi I, Keeley S, Trainor S, Awais O, Shende M, Landreneau RJ, Jobe BA, Pennathur A. Laparoscopic repair of giant paraesophageal hernia results in long-term patient satisfaction and a durable repair. J Gastrointest Surg. 2008 Dec; 12(12):2066-75; discussion 2075-7.
    View in: PubMed
    Score: 0.036
  10. Nason KS, Farrow DC, Haigh G, Lee SP, Bronner MP, Rosen SN, Vaughan TL. Gastric fluid bile concentrations and risk of Barrett's esophagus. Interact Cardiovasc Thorac Surg. 2007 Jun; 6(3):304-7.
    View in: PubMed
    Score: 0.032
  11. Lowenthal BM, Nason KS, Pennathur A, Luketich JD, Pai RK, Davison JM, Ma C. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma. Hum Pathol. 2019 12; 94:1-10.
    View in: PubMed
    Score: 0.019
  12. Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 May; 110(5):662-82; quiz 683.
    View in: PubMed
    Score: 0.014
  13. Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival. Am J Surg Pathol. 2015 Apr; 39(4):487-95.
    View in: PubMed
    Score: 0.014
  14. Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol. 2014 Dec; 27(12):1578-89.
    View in: PubMed
    Score: 0.013
  15. Malhotra U, Zaidi AH, Kosovec JE, Kasi PM, Komatsu Y, Rotoloni CL, Davison JM, R C, Hoppo T, Nason KS, Kelly LA, Gibson MK, Jobe BA. Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium. PLoS One. 2013; 8(11):e78343.
    View in: PubMed
    Score: 0.013
  16. Horne ZD, Jack R, Gray ZT, Siegfried JM, Wilson DO, Yousem SA, Nason KS, Landreneau RJ, Luketich JD, Schuchert MJ. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res. 2011 Nov; 171(1):1-5.
    View in: PubMed
    Score: 0.011
  17. Perry KA, Enestvedt CK, Lorenzo CS, Schipper P, Schindler J, Morris CD, Nason K, Luketich JD, Hunter JG, Jobe BA. The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms. J Gastrointest Surg. 2008 Nov; 12(11):1880-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.